Investors turn to biotech as vaccine roll-out cools sentiment on big pharma

Other sectors set to benefit as lockdown eases

Pedro Gonçalves
clock • 3 min read
Sectors such as telemedicine could boom over the course of the year
Image:

Sectors such as telemedicine could boom over the course of the year

Any halo earned from helping tackle the Covid-19 pandemic is likely to be short-lived for big pharma, according to asset managers who are turning their sights towards biotech and telehealth as the world slowly returns to normal.

On 8 December 2020, England became the first country to roll out a Covid-19 vaccine, a jab developed by Pfizer and BioNTech. In the months leading up to that, the healthcare sector took a leading role...

To continue reading this article...

Join Investment week

  • Unlimited access to real-time news, analysis and opinion from the investment industry, including the Sustainable Hub covering fund news from the ESG space
  • Get ahead of regulatory and technological changes affecting fund management
  • Important and breaking news stories selected by the editors delivered straight to your inbox each day
  • Weekly members-only newsletter with exclusive opinion pieces from leading industry experts
  • Be the first to hear about our extensive events schedule and awards programmes

Join now

 

Already an Investment Week
member?

Login

More on Markets

Industry Voice: Not All Currencies Are Made Equal, So Don't Treat Them as Such

Industry Voice: Not All Currencies Are Made Equal, So Don't Treat Them as Such

Selective currency hedging may boost yields and add stability

Michael Walsh, Multi‑Asset Solutions Strategist at T. Rowe Price
clock 20 May 2022 • 3 min read
UK consumer confidence hits record low as the cost of living crisis deepens

UK consumer confidence hits record low as the cost-of-living crisis deepens

Report by GfK

clock 20 May 2022 • 1 min read
Ron Bundy of Morningstar

Morningstar's Bundy: Why the index industry needs a reset

Victims of their own success

Ron Bundy
clock 17 May 2022 • 2 min read
Trustpilot